Kennedy, per an HHS notice, determined the limited enforcement-discretion policy will curb widespread use of risky foreign-made research-use-only peptides.

has determined that this limited enforcement-discretion policy will discourage the continued, widespread use of certain research-use-only peptides supplied by foreign manufacturers that pose a safety risk to US patients.

Kennedy, per the notice, determined the policy advances patient choice and freedom while appropriately protecting safety.

has determined that the policy advances patient choice and freedom while appropriately protecting patient safety.

Kennedy pledged to hold infant formula makers to rigorous scientific standards, putting babies' health first, as FDA proposed updated nutrient rules.

"Parents deserve confidence in every bottle they feed their baby," ... "We will hold infant formula manufacturers to rigorous scientific standards and put babies' health first."

Kennedy said HHS will hold infant formula makers to rigorous scientific standards and prioritize babies' health.

"Parents deserve confidence in every bottle they feed their baby," HHS Secretary Robert F. Kennedy, Jr. said in a statement, in part. "We will hold infant formula manufacturers to rigorous scientific standards and put babies' health first."

Kennedy decided that HHS's non-enforcement policy on six unapproved peptides advances patient choice and freedom, as stated in an HHS document.

advances patient choice and freedom